Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
23.34
-0.26 (-1.10%)
At close: Feb 18, 2026, 4:00 PM EST
23.34
0.00 (0.00%)
After-hours: Feb 18, 2026, 4:04 PM EST
Fulgent Genetics Market Cap
Fulgent Genetics has a market cap or net worth of $721.5 million as of February 18, 2026. Its market cap has increased by 41.75% in one year.
Market Cap
721.50M
Enterprise Value
-59.02M
1-Year Change
41.75%
Ranking
Category
Stock Price
$23.34
Market Cap Chart
Since September 29, 2016, Fulgent Genetics's market cap has increased from $156.50M to $721.50M, an increase of 361.02%. That is a compound annual growth rate of 17.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 729.50M | -10.17% |
| Dec 31, 2025 | 812.10M | 43.76% |
| Dec 31, 2024 | 564.90M | -34.06% |
| Dec 29, 2023 | 856.70M | -2.28% |
| Dec 30, 2022 | 876.70M | -70.78% |
| Dec 31, 2021 | 3.00B | 137.27% |
| Dec 31, 2020 | 1.26B | 423.90% |
| Dec 31, 2019 | 241.40M | 321.29% |
| Dec 31, 2018 | 57.30M | -26.63% |
| Dec 29, 2017 | 78.10M | -61.81% |
| Dec 30, 2016 | 204.50M | 30.67% |
| Sep 29, 2016 | 156.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veracyte | 2.86B |
| GeneDx Holdings | 2.64B |
| Neogen | 2.39B |
| NeoGenomics | 1.41B |
| CareDx | 1.00B |
| Castle Biosciences | 979.86M |
| OPKO Health | 932.76M |
| Personalis | 765.49M |